INTRODUCTION
Ascorbic acid is a natural, water soluble, slightly acidic vitamin. As it was found that it is used as a vitamin C in animal, then it was renamed as ascorbic acid from L-hexuronic acid. [1] It is an essential nutrient found mainly in fruits and vegetables. It support for maintenance of bones, blood vessels and skins and promotes the healing of cuts, abrasion and wounds. It appears to lessen the risks of developing high blood pressure, heart disease, and also help to regulate the cholesterol level.
[2]
Generally, ascorbic acid is required for collagen formation and tissue repair by acting as a cofactors in the post translational formation of 4-hydroxy proline in Xaa-Pro-Gly sequences in collagens and other proteins. Ascorbic acid is reversibly oxidised to dehydroascorbic acid in the body. These two forms of vitamins are believed to have importance on oxidation-reduction reactions. [3] Ascorbic acid also suppresses the elevation of hepatic mRNA level of hem oxigenase-1, the rate limiting enzyme of bilirubin biosynthesis. [4] Co-trimoxazole or trimethoprim (1): sulfamethoxazole (5) is an antibiotic used in the treatment of variety of bacterial, fungal, protozoal infections. Co-trimoxazole is generally considered bactericidal, although its components are individually bacteriostatic. [5] Its actions are antifolate in nature, inhibiting both De Novo folate biosynthesis and metabolism. [6] Sulfamethoxazole inhibits bacterial synthesis of dihydrofolic acid by competing with PABA (Para Amino Benzoic Acid) and trimethoprim blocks production of tetrahydrofolic acid by inhibiting the enzyme dihydrofolatereductase.
Which blocks two consecutive steps in bacterial biosynthesis of the essential nucleic acid and proteins. [7] Sulfonamide therapy in children lead to hepatic damage during treatment and a liver function test shows the alteration of plasma globulin. [8] Sulfonamide also decreases the activity of glucuronyltransferase in the liver. Thus, it increases the unconjugated bilirubin. Where unconjugated bilirubin causes the nerve cell necrosis.
[9]
Co-trimoxazole was claimed to be more effective than either of its components individually in treating bacterial infections, although this was later disputed. Its use has been restricted in many countries to very specific circumstances where its improved efficacy has been demonstrated.
[10] The global problem of advancing antimicrobial resistance has led to a renewed interest in the use of cotrimoxazole more recently. [11] Sulfamethoxazole displaces bilirubin from binding site on serum albumin. The bilirubin is then free in systemic circulation which leads to hyperbilirubinema. Biliverdin react with biliverdinreductase gives bilirubin on oxidation gives again biliverdine, which have the physiological role as cellular oxidation.
[12]
Bilirubin level in rat; Total bilirubin-0.2-0.55 mg/dl
MATERIALS AND METHODS

Drugs
Co-trimoxazole was purchased from the retail pharmacy ( humidity 50-55%, 12/12 hours light/dark cycle) with free access to a commercial rodent diet and tap water.
Ethical approval
The 
Instruments
Semi-auto analyser-ERBA, CHEM-7
Preparation of drug solution
a) Weigh 162.49 mg of co-trimoxazole powder and dissolve in 15 ml of distilled water, which gives 10 mg/ml concentration.
b) Weigh 1000 mg of ascorbic acid and dissolve in 10 ml of distilled water, which gives 100 mg/ml concentration.
Experimental design
Rats were divided into three groups of six each and the groups were as follows
Group I-control group (No treatment)
Group II-Negative control group treated with co-trimoxazole (36 mg/kg of body weight)
Group III-Test group treated with ascorbic acid (500 mg/kg) and co-trimoxazole (36 mg/kg of body weight)
Animals were marked as head, body, tail and kept in different cages each having 3 animals for their identification.
All the above groups except group I were treated once daily for the period of 15 days.
After one hour of oral administration of dose blood was collected by retro-orbital method on day 1 st , 5 th , 10 th , and day 15 th and bilirubin levels was estimated by semi-auto analyser respectively.
STATISTICAL ANALYSIS
The results were expressed as Mean ± SEM. The differences were compare using One Way Analysis of Variance (ANOVA) and subsequently followed by Tukey's multiple comparison test using Graph Pad Prism-6 software.
RESULTS
Normal group was treated with vehicle i.e. distilled water because in both drug solutions we had used 
DISCUSSION
Hyperbilirubinemia is a common abnormality among patients with notable liver or biliary disease. It may also be observed in patients with systemic illnesses, such as sepsis and cardiogenic shock. The frequencies of the liver and biliary diseases that causes hyperbilirubinemia are described for each specific disease. Most of the drug are metabolised in liver. Normally on hepatic dysfunction, there is increased in bilirubin level. In case of developing countries jaundice is the most common disease mainly symptomized by hyperbilurubinemia as well as on using various drugs, there is a chance of increase in bilirubin level as side effect.
Thousands of biologically active phytochemicals have been identified in plant foods, e.g., grains, nuts, legumes, vegetables, and fruit. Of these plant food groups, vegetables and fruit are the most botanically diverse. [13] The removal of F&V from individual's habitual diets and when they started the basal diet period may have contributed to the bilirubin increase. Li et al. [14] reported that incubation of rat hepatocytes with bilirubin (within the physiological range of serum bilirubin levels in rats) increased UGT1A1 mRNA expression, suggesting that bilirubin modulates its own metabolism.
This may explain in part the reversion to baseline bilirubin concentrations from d 8 to d 15 of the basal diet. [14] Ascorbic acid is a common diet, which have the positive role against hyperbilurubin. On administration of ascorbic acid we can minimise the side effect i.e. hyperbilirubinemia of many drugs by reducing the level of bilirubin. On metabolism of some drug leads to the elevation of hepatic mRNA level of heme oxygenase-1, the rate-limiting enzyme of bilirubin biosynthesis. Due to excessive elimination of the heme oxygenase-1 the bilirubin level increased beyond the limit. Where, ascorbic acid supresses the elevation of hepatic mRNA level of heme oxygenase-1, due to which there is inhibition of excessive production of the bilirubin.
[3] [4] Co-trimoxazole is a broad spectrum antibiotic with a side effect as hyperbilirubinemia on albino rats, which was decreased by given ascorbic acid. It was studied for 15 days on which we found increased bilirubin level on negative control group gradually from day 1 (0.2350±0.0140) to day 15 (0.4800±0.0073) when compared to normal group. Whereas in test group the bilirubin level was significantly decreased from day 1 (0.2150±0.0067) to day 15 (0.2267±0.0080) when compared to negative controlled group. So on co-administration of the ascorbic acid and co-trimoxazole have the beneficial effect over hyperbilirubinemia caused by co-trimoxazole.
Recent work supports the concept that bilirubin functions as an antioxidant at concentrations within the serum reference interval and may provide protection against atherosclerosis, coronary artery disease and inflammation [15, 16] .Increased serum levels of β-carotene, retinol, bilirubin and total antioxidant status are associated with reductions in breast cancer risk [17] .
Emerging work demonstrates that serum bilirubin is a novel biomarker implicated in cardiovascular and metabolic diseases. However, Paul et al. [18] have a limited understanding of the influence of flavonoid-rich fruit and vegetable consumption on bilirubin levels, their findings suggest an association between flavonoid-rich fruit and vegetable consumption and bilirubin levels. If confirmed by prospective and experimental studies, then regular consumption of flavonoid-rich fruits and vegetables should be promoted to increase levels of bilirubin, [18] which can be included as the limitation of our study.
CONCLUSION
From the above results it was concluded that administration of ascorbic acid to rats decreases the hyperbilirubinemia which was induced by Co-trimoxazole. 
